Encephalitis

Encephalitis is an acute inflammation of the brain.

What is Encephalitis?

Encephalitis is a relatively rare condition that causes inflammation of the brain. Initial symptoms usually include high temperature, headache and joint pain but as the infection progresses, more dangerous symptoms may start to develop and include the following...

What Can Aedes Mosquitoes Transmit?

Autoimmune Encephalitis Classification

Autoimmune encephalitis

Autoimmune encephalitis Diagnosis

Autoimmune Encephalitis Pathophysiology

Autoimmune Encephalitis Treatment

What is Anti-NMDA Receptor Encephalitis?

Diagnosis of Anti-NMDA Receptor Encephalitis

Risk Factors for Anti-NMDA Receptor Encephalitis

Treatment and Prognosis of Anti-NMDA Receptor Encephalitis

Latest Encephalitis News and Research

Measles outbreaks increase worldwide with inadequate immunization coverage

Worldwide, there were an estimated 10.3 million cases of measles in 2023, a 20% increase from 2022, according to new estimates from the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC). Inadequate immunization coverage globally is driving the surge in cases.

14 Nov 2024

Metagenomic sequencing improves detection of rare pathogens in CNS infections

New research shows that metagenomic next-generation sequencing (mNGS) over seven years increased pathogen detection in challenging CNS infections, identifying rare and unexpected microbes often missed by standard testing.

13 Nov 2024

Next-generation metagenomic sequencing test quickly detects any kind of pathogen

Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind of pathogen.

12 Nov 2024

Understanding the role of neuroimmune cells in brain health and disease

The brain, traditionally considered an immune-privileged organ due to the blood-brain barrier (BBB), has its own sophisticated immune defense system.

6 Nov 2024

How a ketogenic diet could reduce autoimmune disease severity through host-microbiome interactions

This study uncovers the ketogenic diet's effects on the microbiome, revealing its potential to mitigate autoimmune diseases through metabolic pathways.

6 Nov 2024

Critical protein linked to spillover potential of animal viruses

Scientists investigating animal viruses with potential to infect humans have identified a critical protein that could enable spillover of a family of organisms called arteriviruses.

1 Nov 2024

A review of clinical features, diagnosis, and management of Mpox

A comprehensive review in JAMA outlines monkeypox's clinical presentation and management, stressing the need for increased surveillance and vaccination efforts.

17 Oct 2024

Increasing cases of mosquito-borne diseases call for greater awareness

The hospitalization last summer of Dr. Anthony Fauci, former head of the National Institute of Allergy and Infectious Diseases, with West Nile virus – and his account of it this week in the New York Times – have helped raise public awareness of the dangers of mosquito borne-illness, which can range from Zika and malaria to dengue and West Nile virus.

8 Oct 2024

How viral persistence and immune dysfunction drive long COVID

Study explores the biological drivers and mechanisms of long COVID, shedding light on its epidemiology and potential therapeutic interventions. It emphasizes the role of viral persistence, immune dysfunction, and coagulation in the development of this condition.

29 Sep 2024

NIH funds new research to combat emerging viruses

Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious Diseases (NIAID) to participate in a broad national effort to develop "plug-and-play" vaccines and antibody-based therapies against a wide range of emerging viruses. The grant is part of NIAID's new Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network, which was announced earlier today.

14 Sep 2024

New research network focuses on high-priority viruses

The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most likely to threaten human health with the goal of developing effective vaccines and monoclonal antibodies. Currently, many of the diseases caused by these pathogens have no available vaccines or therapeutics, and investing in this research is key to preparing for potential public health crises-;both in the United States and around the world. NIH's National Institute of Allergy and Infectious Diseases (NIAID) expects to commit approximately $100 million per year to fund the program, pending the availability of funds.

14 Sep 2024

Chinese farmed fur animals found to harbor dozens of novel viruses

Researchers identified 125 virus species in Chinese farmed fur animals, including 36 novel viruses with significant zoonotic potential, emphasizing the need for enhanced surveillance to prevent future pandemics.

9 Sep 2024

How mosquito spit could help develop therapies for arboviral diseases

You might guess it'd be tough to extract saliva from a mosquito. And you'd be correct. Yet, because mosquitos spread disease via saliva, it's critical to sample and study.

5 Sep 2024

New insights into stiff-person syndrome, advancing diagnosis and treatment

Research explores the complexities of diagnosing and treating stiff-person syndrome, emphasizing the uncertain role of GAD antibodies and the promise of novel therapies.

5 Sep 2024

CDC identifies new Oropouche virus cases in U.S. travelers, raising public health concerns

The CDC reports 21 new cases of Oropouche virus among U.S. travelers from Brazil and Cuba, highlighting potential health risks and the need for vigilant monitoring and preventive measures.

29 Aug 2024

Powassan virus in Canada calls for greater vigilance in diagnosing tick-borne encephalitis

With tick-borne viruses such as Powassan virus increasing in Canada, clinicians should consider these infections in patients with encephalitis, as a case study shows in CMAJ.

26 Aug 2024

Disability rights activist pushes government to let him participate in society

Garret Frey refuses to be sidelined. Frey has been paralyzed from the neck down for more than 37 of his 42 years. He has spent decades rejecting the government's excuses when he and others with disabilities are denied the support they need to live in their own homes and to participate in society.

23 Aug 2024